Polarization of Vα24+ Vβ11+ natural killer T cells of healthy volunteers and cancer patients using α-galactosylceramide-loaded and environmentally instructed dendritic cells

Cancer Research

Volumn 63, Issue 14, 2003, Pages 4101-4106

  Van der Vliet, Hans J J ^a   Molling, Johan W ^d   Nishi, Nobusuke ^a,b   Masterson, Allan J ^a   Kölgen, Wendy ^a   Porcelli, Steven A ^c   Van den Eertwegh, Alfons J M ^a   Von Blomberg, B Mary E ^a   Pinedo, Herbert M ^a   Giaccone, Giuseppe ^a   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KIRIN BREWERY CO LTD   (Japan)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CYTOKINE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 15; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INTERLEUKIN 12; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKEMIA CELL LINE; NATURAL KILLER CELL; POLARIZATION; PRIORITY JOURNAL; REGULATORY MECHANISM; TH1 CELL; TH2 CELL; TUMOR IMMUNITY; ADOPTIVE IMMUNOTHERAPY; BIOSYNTHESIS; CELL POLARITY; CYTOLOGY; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM;

ADULT; AGED; ANTIGENS, CD; CELL POLARITY; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GALACTOSYLCERAMIDES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-12; INTERLEUKIN-15; JURKAT CELLS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NEOPLASMS; TH2 CELLS;

EID: 0042173087     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., and Baxter, A. G. NKT cells: facts, functions and fallacies. Immunol. Today, 21: 573-583, 2000.
2. Hayakawa, Y., Takeda, K., Yagita, H., Kakuta, S., Iwakura, Y., van Kaer, L., Saiki, I., and Okumura, K. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur. J. Immunol., 31: 1720-1727, 2001.
3. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/L1 mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med., 187: 1047-1056, 1998.
4. Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., and Berzofsky, J. A. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol., 1: 514-520, 2000.
5. Street, S. E., Cretney, E., and Smyth, M. J. Perforin and interferon-γ independently control tumor initiation, growth, and metastasis. Blood, 97: 192-197, 2001.
6. Smyth, M. J., Thia, K. Y., Street, S. E., Crelney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., and Godfrey, D. I. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med., 191: 661-668, 2000.
7. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Koneka, Y., Koseki, H., Kanno, M., and Taniguchi, M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science (Wash. DC), 278: 1623-1626, 1997.
8. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H., and Taniguchi, M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science (Wash. DC), 278: 1626-1629, 1997.
9. Nakagawa, R., Motoki, K., Ueno, H., Iijima, R., Nakamura, H., Kobayashi, E., Shimosaka, A., and Koezuka, Y. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an α-galactosylceramide, KRN7000. Cancer Res., 58: 1202-1207, 1998.
10. Kawano, T., Nakayama, T., Kamada, N., Kaneko, Y., Harada, M., Ogura, N., Akutsu, Y., Motohashi, S., Iizasa, T., Endo, H., Fujisawa, T., Shinkai, H., and Taniguchi, M. Antitumor cytotoxicity mediated by ligand-activated human Vα24 NKT cells. Cancer Res., 59: 5102-5105, 1999.
11. Tahir, S. M., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G. J., Wilson, S. B., Balk, S. P., and Exley, M. A. Loss of IFN-γ production by invariant NK T cells in advanced cancer. J. Immunol., 167: 4046-4050, 2001.
12. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., Tanaka, Y., and Taniguchi, M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA, 95: 5690-5693, 1998.
13. Giaccone, G., Punt, C. J., Ando, Y., Ruijter, R., Nishi, N., Peters, M., von Blomberg, B. M., Scheper, R. J., van der Vliet, H. J., van den Eertwegh, A. J., Roelvink, M., Beijnen, J., Zwierzina, H., and Pinedo, H. M. A phase 1 study on the NKT cell ligand α-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res., 8: 3702-3709, 2002.
14. Shin, T., Nakayama, T., Akutsu, Y., Motohashi, S., Shibata, Y., Harada, M., Kamada, N., Shimizu, C., Shimizu, E., Saito, T., Ochiai, T., and Taniguchi, M. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Vα14 NKT cells. Int. J. Cancer., 91: 523-528, 2001.
15. Langenkamp, A., Messi, M., Lanzavecchia, A., and Sallusto, F. Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and nonpolarized T cells. Nat. Immunol., 1: 311-316, 2000.
16. Kalinski, P., Hilkens, C. M., Wierenga, E. A., and Kapsenberg, M. L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today, 20: 561-567, 1999.
17. van der Vliet, H. J., Nishi, N., de Gruijl, T. D., von Blomberg, B. M., van den Eertwegh, A. J., Pinedo, H. M., Giaccone, G., and Scheper, R. J. Human natural killer T cells acquire a memory-activated phenotype before birth. Blood, 95: 2440-2442, 2000.
18. Kadowaki, N., Antonenko, S., Ho, S., Rissoan, M-C., Soumelis, V., Porcelli, S. A., Lanier, L. L., and Liu, Y-J. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med., 193: 1221-1226, 2001.
19. Gombert, J. M., Tancrede-Bohin, E., Hameg, A., Leite-de-Moraes, M. C., Vicari, A., Bach, J. F., and Herbelin, A. IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse. Int. Immunol., 8: 1751-1758, 1996.
20. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA, 90: 10188-10192, 1993.
21. van der Vliet, H. J., Nishi, N., Koezuka, Y., von Blomberg, B. M., van den Eertwegh, A. J., Porcelli, S. A., Pinedo, H. M., Scheper, R. J., and Giaccone, G. Potent expansion of human natural killer T cells using α-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J. Immunol. Methods, 247: 61-72, 2001.
22. Bonish, B., Jullien, D., Dutronc, Y., Huang, B. B., Modlin, R., Spada, F. M., Porcelli, S. A., and Nickoloff, B. J. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-γ production by NK-T cells. J. Immunol., 165: 4076-4085, 2000.
23. + T cells to dexamethasone. J. Immunol., 163: 2522-2529, 1999.
24. + T cells in vitro. J. Immunol., 156: 2406-2412, 1996.
25. Metelitsa, L. S., Naidenko, O. V., Kant, A., Wu, H-W., Loza, M. J., Perussia, B., Kronenberg, M., and Seeger, R. C. Human N KT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol., 167: 3114-3122, 2001.
26. + natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells. Immunology, 99: 229-234, 2000.
27. Carnaud, C., Lee, D., Donnars, O., Park, S. H., Beavis, A., Koezuka, Y., and Bendelac, A. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol., 163: 4647-4650, 1999.
28. Nishimura, T., Kitamura, H., Iwakabe, K., Yahata, T., Ohta, A., Sato, M., Takeda, K., Okumura, K., van Kaer, L., Kawano, T., Taniguchi, M., Nakui, M., Sekimoto, M., and Koda, T. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol., 12: 987-994, 2000.
29. Yang, O. O., Racke, F. K., Nguyen, P. T., Gausting, R., Severino, M. E., Horton, H. F., Byrne, M. C., Strominger, J. L., and Wilson, S. B. CD1d on myeloid dendritic cells stimulates cytokine secretion and cytolytic activity of Vα24JαQ T-cells: a feedback mechanism for immune regulation. J. Immunol., 165: 3759-3762, 2000.
30. Schüler, T., Qin, Z., Ibe, S., Noben-Trauth, N., and Blankenstein, T. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J. Exp. Med., 189: 803-810, 1999.
31. + T-cell effector function in situ. Blood. 98: 2143-2151, 2001.
32. O'Garra, A. Cytokines induce the development of functionally heterogenous T helper cell subsets. Immunity, 8: 275-283, 1998.
33. Grogan, J. L., Mohrs, M., Harmon, B., Lacy, D. A., Sedat, J. W., and Locksley, R. M. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity, 14: 205-215, 2001.
34. Healy, C. G., Simons. J. W., Carducci, M. A., de Weese, T. L., Bartkowski, M., Tong, K. P., and Bolton, W. E. Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer. Cytometry, 32: 109-119, 1998.